For a company to be eligible for SME R&D incentives, it must file its accounts as a Going Concern.

This guidance note summarises the Going Concern principle, the responsibilities of both Management and Auditors in assessing its applicability and how the process evolves for both audited and unaudited Life Sciences companies . . .

This content is restricted to subscribers. To view this content please register an account.

Register now

If you are already a subscriber, please login below.